Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
219 Leser
Artikel bewerten:
(0)

Acquisition of Young Innovations, Inc. by Linden Capital Partners May Not Be in Young Innovations' Shareholders' Best Interests

SAN DIEGOand EARTH CITY, Mo., Dec. 4, 2012 /PRNewswire/ -- Shareholder rights attorneys at Robbins Umeda LLP are investigating possible breaches of fiduciary duty and other violations of the law by members of the board of directors of Young Innovations, Inc. (NASDAQ: YDNT) in connection with their efforts to sell the company to an affiliate of Linden Capital Partners.

(Logo: http://photos.prnewswire.com/prnh/20111014/ROBBINSUMEDALOGO)

On December 4, 2012, Young Innovations and Linden Capital announced they had entered into a definitive merger agreement under which Linden Capital will acquire Young Innovations through an all cash tender offer with a total value of $314 million. Young Innovations shareholders will receive $39.50 per share. The transaction is expected to close in the first quarter of 2013.

The Board of Directors' Actions May Prevent Young Shareholders from Receiving the Maximum Value for Their Stock

Robbins Umeda LLP's investigation focuses on whether the board of directors at Young Innovations is undertaking a fair process to obtain maximum value and adequately compensate its shareholders. The $39.50 per share offer price represents a premium of only 8.7% based on Young Innovations' closing price on December 3, 2012, and is below the $40.44 per share price the Company's stock traded at on October 1, 2012. Further, Young Innovations reported its third quarter 2012 financial results reflecting a 3.5% increase in sales for the quarter, and a 6.0% increase in income from operations. Young Innovations also reported diluted earnings per share for the fiscal third quarter 2012 of $0.54, compared to analyst estimates of $0.51. Moreover, Young Innovations has beat analyst earnings per share estimates in six of the past eight quarters. Given these financials, the firm is examining the board of directors' decision to sell Young Innovations now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects.

Young Innovations shareholders have the option to file a class action lawsuit against the company to secure the best possible price for shareholders and the disclosure of material information so shareholders can vote on the transaction in an informed manner. Young Innovations shareholders interested in information about their rights and potential remedies can contact Darnell R. Donahue at (800) 350-6003, ddonahue@robbinsumeda.com, or via the shareholder information form on the firm's website.

Robbins Umeda LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsumeda.com.

Press release link:
http://www.robbinsumeda.com/shareholders-rights-blog/young-innovations-inc/

Attorney Advertising. Past results do not guarantee a similar outcome.

Contact:
Robbins Umeda LLP
Darnell R. Donahue
ddonahue@robbinsumeda.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsumeda.com

SOURCE Robbins Umeda LLP

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.